# Harmony Biosciences Holdings, Inc. (HRMY)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HRMY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 215.39M | $ 32.49M | $ 27.76M | $ 206.52M | $ 910.35M |
| 2025 | $ 889.22M | $ 162.48M | $ 356.21M | $ 239.58M | $ 870.22M |
| 2024 | $ 751.24M | $ 152.92M | $ 229.84M | $ 181.41M | $ 659.16M |
| 2023 | $ 629.31M | $ 139.32M | $ 236.88M | $ 196.09M | $ 466.99M |
| 2022 | $ 489.13M | $ 202.72M | $ 161.19M | $ 191.65M | $ 402.84M |
| 2021 | $ 363.06M | $ 41.12M | $ 116.80M | $ 195.74M | $ 186.51M |
| 2020 | $ 203.50M | $ -47.07M | $ -3.81M | $ 194.25M | $ 97.18M |
| 2019 | $ 7.74M | $ -196.16M | $ -162.10M | $ 97.95M | $ -11.59M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.23 |
| Liabilities / Eq | 0.40 |
| Current Ratio | 3.58 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 2.54 |
| Gross Debt / FCF | 1.39 |

## Other views

- [Metrics](https://sponda.capital/en/HRMY.md)
- [Charts](https://sponda.capital/en/HRMY/charts.md)
- [Compare](https://sponda.capital/en/HRMY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.